ATC code M05

ATC codes
M Musculo-skeletal system
M01 Anti-inflammatory and antirheumatic products
M02 Topical products for joint and muscular pain
M03 Muscle relaxants
M04 Antigout preparations
M05 Drugs for treatment of bone diseases
M09 Other drugs for disorders of the musculo-skeletal system

ATC code M05 Drugs for treatment of bone diseases is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the World Health Organization (WHO) for the classification of drugs and other medical products.[1][2][3] Subgroup M05 is part of the anatomical group M Musculo-skeletal system.[4]

Codes for veterinary use (ATCvet codes) can be created by placing the letter Q in front of the human ATC code: for example, QM05.[5]

National issues of the ATC classification may include additional codes not present in this list, which follows the WHO version.

M05B Drugs affecting bone structure and mineralization

M05BA Bisphosphonates

M05BA01 Etidronic acid
M05BA02 Clodronic acid
M05BA03 Pamidronic acid
M05BA04 Alendronic acid
M05BA05 Tiludronic acid
M05BA06 Ibandronic acid
M05BA07 Risedronic acid
M05BA08 Zoledronic acid

M05BB Bisphosphonates, combinations

M05BB01 Etidronic acid and calcium, sequential
M05BB02 Risedronic acid and calcium, sequential
M05BB03 Alendronic acid and colecalciferol
M05BB04 Risedronic acid, calcium and colecalciferol, sequential
M05BB05 Alendronic acid, calcium and colecalciferol, sequential
M05BB06 Alendronic acid and alfacalcidol, sequential
M05BB07 Risedronic acid and colecalciferol
M05BB08 Zoledronic acid, calcium and colecalciferol, sequential
M05BB09 Ibandronic acid and colecalciferol

M05BC Bone morphogenetic proteins

M05BC01 Dibotermin alfa
M05BC02 Eptotermin alfa

M05BX Other drugs affecting bone structure and mineralization

M05BX01 Ipriflavone
M05BX02 Aluminium chlorohydrate
M05BX03 Strontium ranelate
M05BX04 Denosumab
M05BX05 Burosumab
M05BX06 Romosozumab
M05BX07 Vosoritide
M05BX53 Strontium ranelate and colecalciferol

References

  1. "ATC (Anatomical Therapeutic Chemical Classification System) – Synopsis". National Institutes of Health. Retrieved 1 February 2020.
  2. World Health Organization. "Anatomical Therapeutic Chemical (ATC) Classification". World Health Organization. Retrieved 3 January 2022.
  3. "Structure and principles". WHO Collaborating Centre for Drug Statistics Methodology. 15 February 2018. Retrieved 3 January 2022.
  4. "ATC/DDD Index 2022: code M05". WHO Collaborating Centre for Drug Statistics Methodology.
  5. "ATCvet Index 2022: code QM05". WHO Collaborating Centre for Drug Statistics Methodology.
This article is issued from Offline. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.